Two Natural Weapons for the Brain:
The Cognitive Science of Lion's Mane Mushroom and Ashwagandha
According to the World Health Organization (WHO), approximately 55 million people worldwide were living with dementia as of 2023, with a new case emerging every 3 seconds. More concerning still is Mild Cognitive Impairment (MCI), which manifests years before progression to dementia. An estimated 15–20% of adults aged 65 and older are in an MCI state, with 10–15% of that group progressing to Alzheimer's disease each year — a pattern consistently observed in the medical literature.
Against this backdrop, two functional ingredients have drawn significant attention for their neuroprotective effects through two distinct pathways: "neurotrophic factor activation" and "stress hormone blockade." These are Lion's Mane mushroom (Hericium erinaceus) and Ashwagandha (Withania somnifera). Both ingredients possess data verified through the rigorous methodology of randomized double-blind placebo-controlled clinical trials (RCTs), placing them among the rare functional food ingredients with a relatively high level of evidence.
PART 1 · Lion's Mane Mushroom — The Brain's Gardener That Awakens NGF Synthesis
1-1. What Is NGF: The Brain's Maintenance Protein
Nerve Growth Factor (NGF) is a protein discovered in the 1950s by Italian neuroscientist Rita Levi-Montalcini (Nobel Prize in Physiology or Medicine, 1986) that directly regulates the survival, growth, and differentiation of neurons. It is especially essential for maintaining cholinergic neurons that govern the hippocampus and prefrontal cortex — the core structures of memory and learning. Multiple neuropathological studies have repeatedly confirmed that the NGF signaling system is significantly impaired in the brains of Alzheimer's patients.
The challenge is that NGF cannot directly cross the blood-brain barrier (BBB). Therefore, rather than raising circulating NGF levels in the bloodstream, the key research direction has been finding substances that stimulate the brain's own NGF synthesis from within. This is precisely where Lion's Mane mushroom enters the picture.
1-2. Hericenones & Erinacines: Two Key Compounds That Cross the BBB
Two classes of NGF-inducing compounds have been identified in Lion's Mane mushroom. Hericenones A–H, isolated from the fruiting body, and Erinacines A–I, isolated from the mycelium.
Hericenones
Aromatic compounds extracted from the fruiting body. In vitro studies show significant promotion of NGF biosynthesis in brain neurons. Lipid composition enables good cell membrane permeability.
Erinacines
Diterpenoid compounds extracted from the mycelium. Their lipophilic nature allows confirmed potential to cross the blood-brain barrier (BBB). Animal models show significant elevation of NGF levels within the brain.
In an animal model study of Erinacine A (Mori K, et al., Biomedical Research, 2008), rats administered Erinacine A showed significantly increased NGF mRNA expression in the brain — particularly in the hypothalamus and brainstem. This indicates that erinacines stimulate NGF synthesis directly within the central nervous system, not merely in peripheral tissue.
1-3. Results from a Human Double-Blind Clinical Trial (Mori et al., 2009)
The pivotal human clinical trial validating Lion's Mane mushroom's cognitive enhancement effect is a double-blind placebo-controlled study published in 2009 by a Japanese research team led by Mori S in Phytotherapy Research (Vol. 23, No. 3, pp. 367–372).
📋 Mori et al. (2009) Clinical Trial Overview
· Subjects: 30 adults with diagnosed Mild Cognitive Impairment (MCI), aged 50–80, randomly assigned
· Treatment group: Lion's Mane mushroom extract 250 mg tablets × 4 tablets × 3 times/day (equivalent to 3 g total) — 16 weeks
· Placebo group: Identical-appearing placebo tablets — same duration
· Assessment scale: Cognitive function scores based on the Revised Hasegawa Dementia Scale (HDSR)
· Results: At all time points — 8, 12, and 16 weeks — the treatment group scored statistically significantly higher than the placebo group in cognitive function (p < 0.05)
· Post-discontinuation observation: At 28 weeks (4 weeks after stopping), the score difference between groups disappeared → implies importance of continuous intake
This study is significant on several levels. First, it tracked effects over a full 16-week period, overcoming the common limitation of short-term evaluation in functional food research. Second, the observed decline after discontinuation supports the hypothesis that Lion's Mane mushroom's effects relate to sustained "maintenance of the brain environment" rather than acting as a transient stimulant.
PART 2 · Ashwagandha — Cortisol: The Brain's Quietest Enemy
2-1. The Pathway by Which Chronic Stress Destroys the Brain
Decades of neuroendocrinological research — including studies by Stanford University's Robert Sapolsky — converge on a common conclusion: chronically elevated cortisol directly damages neurons in the hippocampus. Cortisol binds to glucocorticoid receptors in the hippocampus and overstimulates them; when sustained over time, this leads to dendritic atrophy and reduction in hippocampal volume. The correlation between stress and impaired memory and concentration has a clear neurobiological mechanism — not simply "fatigue."
For seniors, this problem is more acute. Due to age-related decline in HPA axis (hypothalamic-pituitary-adrenal axis) regulatory function, older adults tend to have cortisol levels that rise higher and remain elevated longer in response to the same stressors. This creates a vicious cycle of cognitive decline, sleep disturbance, and immune dysfunction.
2-2. Withanolides: The Core Active Compounds of Ashwagandha
Ashwagandha (Withania somnifera) is an adaptogenic plant used in Indian Ayurvedic medicine for over 5,000 years, and its principal active compounds are now well-characterized. The steroidal lactone compounds collectively called Withanolides are the key active constituents, with Withanolide A and Withaferin A in particular being closely associated with HPA axis regulation and anti-neuroinflammatory effects. The most commonly used commercial standardized extracts in clinical research are KSM-66 (natural-process extract, 5% withanolides standardized) and Sensoril (water-soluble extract, 10% withanolides standardized).
2-3. Key Data from Double-Blind Clinical Trial: 27.9% Cortisol Reduction
📋 Chandrasekhar et al. (2012) — Key Clinical Data
Source: Indian Journal of Psychological Medicine, 34(3), 255–262
· Design: Randomized double-blind placebo-controlled (Gold Standard RCT)
· Subjects: 64 adults reporting chronic stress
· Intervention: KSM-66 Ashwagandha root extract 300 mg × 2 times/day (600 mg total) vs. placebo — 60 days
· Serum cortisol change: Treatment group 27.9% reduction / Placebo group 7.9% reduction (p = 0.0006)
· Perceived Stress Scale (PSS) improvement: Treatment group 44.0% / Placebo group 5.5%
· Safety: No difference in adverse events vs. placebo (excellent tolerability)
A p-value of 0.0006 represents extremely strong statistical significance (p < 0.001). This means the probability of this result occurring by chance under these conditions is just 0.06% — indicating that Ashwagandha's cortisol-suppressing effect far exceeds simple placebo effect.
Additionally, Pratte MA et al. (2014, Alternative Therapies in Health and Medicine) independently confirmed that Ashwagandha root extract significantly improved perceived stress and sleep quality — representing an independent replication of the Chandrasekhar findings.
PART 3 · An Integrated Perspective for Seniors: The Complementary Roles of Both Ingredients
Lion's Mane mushroom and Ashwagandha approach brain health through distinct pathways. Lion's Mane focuses on supplying neural regenerative resources (promoting NGF synthesis), while Ashwagandha focuses on blocking neural destructive forces (suppressing excess cortisol). When these two actions combine, a dual line of neuroprotection is formed — a hypothesis some researchers describe as "Neural Environment Optimization."
| Category | Lion's Mane Mushroom | Ashwagandha |
|---|---|---|
| Primary Mechanism | NGF synthesis promotion → cholinergic neuron protection | HPA axis regulation → cortisol reduction |
| Key Active Compounds | Hericenones, Erinacines | Withanolide A, Withaferin A |
| Clinical Evidence Level | 1+ RCT, multiple observational studies | Multiple RCTs, including meta-analyses |
| Clinical Dose (Research-Based) | 3 g/day fruiting body powder (or 1 g extract) | 300–600 mg/day standardized extract |
| Time to Effect | After 4–8+ weeks of continuous use | After 4–8+ weeks of continuous use |
| Key Precautions | Caution with mushroom allergy; possible interaction with anticoagulants | Caution in hyperthyroidism; contraindicated in pregnancy; possible interaction with some sedatives |
Practical Guide for Seniors and Caregivers
- Lion's Mane mushroom: Based on regulatory standards and major clinical research, take 3 g/day of fruiting body powder or 1 g of extract with meals. A quality-certified standardized product is preferable to unregulated single supplements.
- Ashwagandha: Based on standardized extracts such as KSM-66 or Sensoril, take 300–600 mg/day. In most clinical trials, dosing schedules used before or after dinner or 30 minutes before bedtime.
- At least 8 weeks of consistent use: Both ingredients show effects after 4–8 weeks of cumulative intake. Effects cannot be properly assessed with short-term use of 2–3 weeks.
- Mandatory physician consultation when combining with medications: If you are taking anticoagulants (warfarin, aspirin), anxiolytics, sedatives, or thyroid medications, always consult a physician or pharmacist before deciding to take these supplements.
- Monitor sleep quality: Ashwagandha has also been reported to improve sleep quality. Keeping a record of sleep pattern changes after starting supplementation helps confirm effectiveness.
- Supplements are a "complement" to a balanced diet: No supplement can replace a Mediterranean-style diet, regular exercise, or social engagement. Cognitive protection effects are maximized when used in conjunction with these lifestyle factors.
Key References & Data Sources
- Mori S, Inatomi S, Ouchi K, et al. "Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial." Phytotherapy Research. 2009;23(3):367–372. [PubMed PMID: 18844328]
- Mori K, Inatomi S, Ouchi K, et al. "Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells." Biomedical Research. 2008;29(4):175–179.
- Lai PL, Naidu M, Sabaratnam V, et al. "Neurotrophic properties of the Lion's mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia." International Journal of Medicinal Mushrooms. 2013;15(6):539–554.
- Chandrasekhar K, Kapoor J, Anishetty S. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine. 2012;34(3):255–262. [PubMed PMID: 23439798]
- Pratte MA, Nanavati KB, Young V, Morley CP. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera)." Alternative Therapies in Health and Medicine. 2014;20(1):24–31.
- WHO. "Dementia." World Health Organization Fact Sheet. 2023. who.int
Frequently Asked Questions (FAQ)
Does cooking Lion's Mane mushroom still provide the NGF-inducing effect?
Hericenones and erinacines are relatively heat-stable and some remain after cooking, but consuming the same concentrations used in clinical trials through cooking alone is difficult. Standardized extracts were used in research. Consuming it as a food is still beneficial, but for cognitive support purposes, standardized supplement forms offer more consistent dosing.
If Ashwagandha lowers cortisol, won't it also reduce immunity?
Cortisol itself has anti-inflammatory properties, but chronically excessive cortisol actually suppresses the immune system. Ashwagandha acts as an "adaptogen" — modulating cortisol that has risen excessively above normal back toward physiological levels. Clinical trials have also reported improvements in immune markers (such as NK cell activity) following Ashwagandha supplementation, so concerns about immune suppression have low evidential support.
Is it safe to take both supplements together?
To date, formal safety studies examining the simultaneous use of Lion's Mane mushroom and Ashwagandha are limited. Each ingredient individually has been reported to have excellent tolerability in short-term (8–16 week) clinical trials. However, seniors taking other medications should always consult a physician or pharmacist before making that decision.
Can these supplements still help if an Alzheimer's diagnosis has already been made?
The primary clinical trials on Lion's Mane mushroom were conducted at the "Mild Cognitive Impairment (MCI)" stage. Evidence for effectiveness in already-progressed Alzheimer's disease is currently insufficient, and in that case pharmaceutical treatment takes priority. Functional supplements should only be considered as adjunctive support to existing treatment, and must be approached under the guidance of qualified medical professionals.